| pubmed-article:11516215 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C2243049 | lld:lifeskim |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C0521447 | lld:lifeskim |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C0023810 | lld:lifeskim |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C0032535 | lld:lifeskim |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C0086982 | lld:lifeskim |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C1446680 | lld:lifeskim |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:11516215 | lifeskim:mentions | umls-concept:C1547200 | lld:lifeskim |
| pubmed-article:11516215 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11516215 | pubmed:dateCreated | 2001-8-22 | lld:pubmed |
| pubmed-article:11516215 | pubmed:abstractText | There have been many studies on anti-lipopolysaccharide (LPS) agents and LPS-neutralizing agents; however, there have been no reports on the changes in clinical status and mediators that occur when these agents are used. Polymyxin (PMX) (treatment using a column containing polymyxin B-immobilized fiber) removed circulating endotoxin, and reduced various cytokines within 120 min, even in patients with high levels of plasma cytokines. Our purpose was examine the mechanisms of PMX treatment by which plasma cytokines are reduced by endotoxin neutralization with polymyxin B, even during therapy for sepsis and/or endotoxin shock. | lld:pubmed |
| pubmed-article:11516215 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11516215 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11516215 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11516215 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11516215 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11516215 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11516215 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11516215 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11516215 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11516215 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11516215 | pubmed:issn | 0022-4804 | lld:pubmed |
| pubmed-article:11516215 | pubmed:author | pubmed-author:TsuzukiHH | lld:pubmed |
| pubmed-article:11516215 | pubmed:author | pubmed-author:KodamaMM | lld:pubmed |
| pubmed-article:11516215 | pubmed:author | pubmed-author:UeyamaHH | lld:pubmed |
| pubmed-article:11516215 | pubmed:author | pubmed-author:TaniTT | lld:pubmed |
| pubmed-article:11516215 | pubmed:copyrightInfo | Copyright 2001 Academic Press. | lld:pubmed |
| pubmed-article:11516215 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11516215 | pubmed:volume | 100 | lld:pubmed |
| pubmed-article:11516215 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11516215 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11516215 | pubmed:pagination | 127-34 | lld:pubmed |
| pubmed-article:11516215 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:meshHeading | pubmed-meshheading:11516215... | lld:pubmed |
| pubmed-article:11516215 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11516215 | pubmed:articleTitle | Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation. | lld:pubmed |
| pubmed-article:11516215 | pubmed:affiliation | First Department of Surgery, Shiga University of Medical Science, Seta-tsukinowa-cho, Otsu-city, Shiga, 520-2192, Japan. tsuzukih@smile.ocn.ne.jp | lld:pubmed |
| pubmed-article:11516215 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11516215 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11516215 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11516215 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11516215 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11516215 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11516215 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11516215 | lld:pubmed |
